Smith A, Morgan W T
Biochem J. 1979 Jul 15;182(1):47-54. doi: 10.1042/bj1820047.
Rat [(59)Fe]haem-(125)I-labelled haemopexin complexes (700pmol/rat) associate rapidly and exclusively with the liver after intravenous injection into anaesthetized rats. The two isotopes exhibit different patterns of accumulation. Liver (125)I-labelled haemopexin is maximum 10min after injection (20+/-4.9pmol/g of liver) and then declines by 2h to the low values (about 3pmol/g of liver) seen after injection of the apoprotein. In contrast, [(59)Fe]haem accumulates in the liver for at least 2h. Haemopexin undergoes no extensive proteolysis during 2h of haem transport as shown by precipitation with acid (98%) and specific antiserum (92%) and by electrophoresis. Moreover, only 1-2% of the dose is located in extrahepatic tissues, and there is no significant urinary excretion of either (125)I or (59)Fe. Hepatic uptake at 10min is saturable, reaching 200pmol of haemopexin/g of liver and 350pmol of haem/g of liver at a dose of 9nmol/rat, whereas uptake of the apoprotein is 3-5% of the dose. This suggests that the interaction of haem-haemopexin with the liver is a specific receptor-mediated process. The complex probably interacts via the protein moiety, since the haem analogues mesohaem and deuterohaem do not affect association of the protein with the liver but the species of haemopexin does. Increasing amounts of protein are associated with the liver 5min after injection in the order: human>rabbit>rat, and haem uptake is consistently increased. For both rat and rabbit haemopexin saturation is reached at the same concentration of protein, i.e. 180-200pmol/g of liver, indicating that the different protein species bind to a common receptor. We propose that haemopexin transports haem to the liver by a specific receptor-mediated process and then returns to the circulation.
将[(59)Fe]血红素-(125)I标记的血红素结合蛋白复合物(700皮摩尔/大鼠)静脉注射到麻醉的大鼠体内后,它会迅速且专一性地与肝脏结合。这两种同位素呈现出不同的积累模式。肝脏中(125)I标记的血红素结合蛋白在注射后10分钟达到最大值(20±4.9皮摩尔/克肝脏),然后在2小时内下降至注射脱辅基蛋白后所见的低值(约3皮摩尔/克肝脏)。相比之下,[(59)Fe]血红素在肝脏中至少积累2小时。如用酸沉淀(98%)、特异性抗血清沉淀(92%)以及电泳所示,在2小时的血红素转运过程中,血红素结合蛋白未发生广泛的蛋白水解。此外,只有1 - 2%的剂量位于肝外组织,并且(125)I或(59)Fe均无明显的尿排泄。10分钟时的肝脏摄取是可饱和的,在剂量为9纳摩尔/大鼠时,达到200皮摩尔血红素结合蛋白/克肝脏和350皮摩尔血红素/克肝脏,而脱辅基蛋白的摄取量为剂量的3 - 5%。这表明血红素 - 血红素结合蛋白与肝脏的相互作用是一个特定的受体介导过程。该复合物可能通过蛋白质部分相互作用,因为血红素类似物中血红素和氘代血红素不影响该蛋白质与肝脏的结合,但血红素结合蛋白的种类会影响。注射后5分钟,与肝脏结合的蛋白量按以下顺序增加:人>兔>大鼠,并且血红素摄取持续增加。对于大鼠和兔的血红素结合蛋白,在相同的蛋白浓度即180 - 200皮摩尔/克肝脏时达到饱和,这表明不同的蛋白质种类与共同的受体结合。我们提出,血红素结合蛋白通过特定的受体介导过程将血红素转运至肝脏,然后再返回循环系统。